edrophonium has been researched along with n-methylscopolamine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Brockmöller, J; Dücker, C; Jensen, O | 1 |
Cryer, PE; Leveston, SA | 1 |
Endou, M; Gamoh, M; Hirose, Y; Miwa, T; Nakaya, H; Okumura, F; Tanito, Y | 1 |
3 other study(ies) available for edrophonium and n-methylscopolamine
Article | Year |
---|---|
Identification of Novel High-Affinity Substrates of OCT1 Using Machine Learning-Guided Virtual Screening and Experimental Validation.
Topics: Databases, Chemical; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Machine Learning; Octamer Transcription Factor-1; Organic Chemicals | 2021 |
Endogenous cholinergic modulation of growth-hormone secretion in normal and acromegalic humans.
Topics: Acromegaly; Adult; Cholinesterase Inhibitors; Edrophonium; Female; Growth Hormone; Humans; Kinetics; Male; N-Methylscopolamine; Parasympatholytics; Prolactin; Scopolamine Derivatives | 1980 |
Interaction of edrophonium with muscarinic acetylcholine M2 and M3 receptors.
Topics: Animals; Bronchoconstriction; Carbachol; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Edrophonium; Guinea Pigs; Heart Rate; Male; N-Methylscopolamine; Potassium Channels; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptors, Muscarinic | 2001 |